國立高雄大學圖資館 |

Oncologygenomics, precision medicine and therapeutic targets /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Oncologyedited by Hardeep Singh Tuli, Mükerrem Betül Yerer Aycan.
其他題名:	genomics, precision medicine and therapeutic targets /
其他作者:	Tuli, Hardeep Singh.
出版者:	Singapore :Springer Nature Singapore :2023.
面頁冊數:	xvi, 274 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	CancerTreatment.
電子資源:	https://doi.org/10.1007/978-981-99-1529-3
ISBN:	9789819915293$q(electronic bk.)

Oncologygenomics, precision medicine and therapeutic targets /
Oncologygenomics, precision medicine and therapeutic targets /[electronic resource] :edited by Hardeep Singh Tuli, Mükerrem Betül Yerer Aycan. - Singapore :Springer Nature Singapore :2023. - xvi, 274 p. :ill., digital ;24 cm.

Chapter 1 Evolution of translational cancer therapeutics -- Chapter 2 Oncology: Way forward from clinical and molecular diagnosis to treatment -- Chapter 3 Oncogenic genomics alterations in cancer patient -- Chapter 4 Altered mRNA expression profiles in cancer patients -- Chapter 5 microRNAs and long non-coding RNAs as key targets -- Chapter 6 Oncogenic alterations translated into diagnostics -- Chapter 7 Precision medicine in oncology -- Chapter 8 Precision medicine - translation of individualistic treatment in oncology -- Chapter 9Pharmacogenetics and Pharmacogenomics in Precision Medicine -- Chapter 10 Pharmacogenetic factors in pharmacodynamic/pharmacokinetic (PD/PK) modulations of medicines -- Chapter 11 Biomarkers in Precision Medicine in oncology -- Chapter 12 Bioinformatics and biostatistics in Precision Medicine -- Chapter 13 Omics in Precision medicine -- Chapter 14 Translational therapeutic targets : from bench to clinical trials -- Chapter 15 Strength of integartive genomic alterations, precision medicine and therapeutic targets as treatment choice in patient care.

This book describes translational cancer therapeutics and the way forward from clinical and molecular diagnosis to treatment. In addition, genomics alterations, microRNAs, and long non-coding RNAs translate precision medicine for the individualistic therapy of cancer patients. It describes the involvement of various pharmacogenetic factors in pharmacodynamic/pharmacokinetic (PD/PK) modulations of medicines. Indeed, the role of bioinformatics and biostatistics, considering the extensive data analysis serving precision medicine approaches, has also been entertained in the present book. Therefore, intended book demonstrates the successful medical evidence for the use of precision medicine in the treatment of cancer and its future clinical perspectives. It fills the gaps in cancer biology and precision medicine with its up-to-date content and well-designed chapters. It will serve as a valuable resource for science, medical students, and interdisciplinary researchers. It is a very welcome addition for the scientific community, research centers, and university-industry research collaborators to find out a complete capsular package about cancer drug targets, precision, and personalized medicine (including an introduction to cancer cell signaling, genomic alterations, miRNA targeting, pharmacogenetics, biomarkers, and metabolomics in precision medicine, etc.) at a single platform.

ISBN: 9789819915293$q(electronic bk.)

Standard No.: 10.1007/978-981-99-1529-3doiSubjects--Topical Terms:

252269
Cancer
--Treatment.

LC Class. No.: RC270.8 / .O53 2023

Dewey Class. No.: 616.99406

Oncologygenomics, precision medicine and therapeutic targets /
LDR:03535nmm a2200325 a 4500 001 646692
003 DE-He213
005 20230630085024.0
006 m d
007 cr nn 008maaau
008 240116s2023 si s 0 eng d
020 $a 9789819915293$q(electronic bk.)
020 $a 9789819915286$q(paper)
024 7 $a 10.1007/978-981-99-1529-3 $2 doi
035 $a 978-981-99-1529-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8 $b .O53 2023
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .O58 2023
245 0 0 $a Oncology $h [electronic resource] : $b genomics, precision medicine and therapeutic targets / $c edited by Hardeep Singh Tuli, Mükerrem Betül Yerer Aycan.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xvi, 274 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 Evolution of translational cancer therapeutics -- Chapter 2 Oncology: Way forward from clinical and molecular diagnosis to treatment -- Chapter 3 Oncogenic genomics alterations in cancer patient -- Chapter 4 Altered mRNA expression profiles in cancer patients -- Chapter 5 microRNAs and long non-coding RNAs as key targets -- Chapter 6 Oncogenic alterations translated into diagnostics -- Chapter 7 Precision medicine in oncology -- Chapter 8 Precision medicine - translation of individualistic treatment in oncology -- Chapter 9Pharmacogenetics and Pharmacogenomics in Precision Medicine -- Chapter 10 Pharmacogenetic factors in pharmacodynamic/pharmacokinetic (PD/PK) modulations of medicines -- Chapter 11 Biomarkers in Precision Medicine in oncology -- Chapter 12 Bioinformatics and biostatistics in Precision Medicine -- Chapter 13 Omics in Precision medicine -- Chapter 14 Translational therapeutic targets : from bench to clinical trials -- Chapter 15 Strength of integartive genomic alterations, precision medicine and therapeutic targets as treatment choice in patient care.
520 $a This book describes translational cancer therapeutics and the way forward from clinical and molecular diagnosis to treatment. In addition, genomics alterations, microRNAs, and long non-coding RNAs translate precision medicine for the individualistic therapy of cancer patients. It describes the involvement of various pharmacogenetic factors in pharmacodynamic/pharmacokinetic (PD/PK) modulations of medicines. Indeed, the role of bioinformatics and biostatistics, considering the extensive data analysis serving precision medicine approaches, has also been entertained in the present book. Therefore, intended book demonstrates the successful medical evidence for the use of precision medicine in the treatment of cancer and its future clinical perspectives. It fills the gaps in cancer biology and precision medicine with its up-to-date content and well-designed chapters. It will serve as a valuable resource for science, medical students, and interdisciplinary researchers. It is a very welcome addition for the scientific community, research centers, and university-industry research collaborators to find out a complete capsular package about cancer drug targets, precision, and personalized medicine (including an introduction to cancer cell signaling, genomic alterations, miRNA targeting, pharmacogenetics, biomarkers, and metabolomics in precision medicine, etc.) at a single platform.
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Cancer $x Genetic aspects. $3 189391
650 0 $a Precision medicine. $3 955732
650 1 4 $a Cancer Biology. $3 920982
650 2 4 $a Cancer Genetics and Genomics. $3 918740
650 2 4 $a Oncology. $3 195181
650 2 4 $a Therapeutics. $3 218144
700 1 $a Tuli, Hardeep Singh. $3 877021
700 1 $a Yerer Aycan, Mukerrem Betul. $3 955731
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-1529-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)